AC T02259
XX
ID T02259
XX
DT 07.11.1997 (created); ili.
DT 07.07.2008 (updated); nhb.
CO Copyright (C), QIAGEN.
XX
FA PEBP2beta-isoform1
XX
SY CBFbeta; core-binding factor, beta subunit; PEBP2beta.
XX
OS human, Homo sapiens
OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates
XX
GE G004693 CBFB; HGNC: CBFB.
XX
CL C0029; runt.
XX
SZ 182 AA; 21.5 kDa (cDNA) (calc.).
XX
SQ MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVAT
SQ GTNLSLQFFPASWQGEQRQTPSREYVDLEREAGKVYLKAPMILNGVCVIWKGWIDLQRLD
SQ GMGCLEFDEERAQQEDALAQQAFEEARRRTREFEDRDRSHREEMEVRVSQLLAVTGKKTT
SQ RP
XX
SC Swiss-Prot#Q13951
XX
FT 1 178 
PF02312; Core binding factor beta subunit.
XX
SF very similar to mouse PEBP2beta-isoform12 T01065;
XX
FF associated with inv(16) leukemia, in which all but the last 22 AA are fused to smooth muscle myosin heavy chain (SMMHC) [1];
XX
IN T02235 PEBP2alphaB1; mouse, Mus musculus.
XX
MX M03841 V$PEBP2B_Q6.
MX M00984 V$PEBP_Q6.
XX
BS R05031.
BS R05032.
XX
DR TRANSPATH: MO000026266.
DR EMBL: L20298;
DR UniProtKB: Q13951;
XX
RN [1]; RE0006065.
RX PUBMED: 8164679.
RA Bae S., Ogawa E., Maruyama M., Oka H., Satake M., Shigesada K., Jenkins N. A., Gilbert D. J., Copelands N. G., Ito Y.
RT PEBP2alphaB / mouse AML1 consists of multiple isoforms that possess differential transactivation potentials
RL Mol. Biol. Cell 14:3242-3252 (1994).
XX
//